L10012A | PLLA is an acid terminated Pharma / Medical Grade homopolymer of L-lactide with an inherent viscosity midpoint of 1.0 dl/g. It is supplied in the form of white micronized powder. L10012A is primarily used for Drug delivery formulations, Drug-eluting stents, ACL Scrow, and bio-stimulatory dermal filler.
Product Description
| CAS Number | 26100-51-6 |
| Systematic Name | Poly(2-hydroxy propionic acid), Polylactic acid, Poly lactide, Poly L lactide, Injectable Poly-l-lactic Acid, Ultra-Pure PLLA. |
| Molecular Formula | ((C3H4O2)n |
| EPA Registry Name | Polylactic acid |
| Former CAS Number(s): | 1104201-86-6, 31587-11-8, 1148011-07-7, 947236-64-8, 1384255-85-9 |
| Substance Type | PLA | L10012A | Inherent Viscosity : 0.90 - 1.20 dL/g | Acid terminated |L- Lactide 100% | Mw 100-140 kDa Biodegradable Polymer, Excipient, Non-Active pharmaceutical ingredient, Nanoparticles. |
| Synonym | PLA, Poly(L-lactide) acid terminated, PLLA |
| Applications | Drug delivery formulations, Drug-eluting stents, ACL Scrow, bio-stimulatory dermal filler. |
Specification
| Appearance | White powder. |
| Solubility | Soluble in methylene chloride. Insoluble in water. |
| FT NMR (PROTON) | Should comply |
| Viscosity (0.5% in CHCl3 at 30°C) | Between 0.90-1.20 dL/g |
| Residual monomer L-Lactide | ≤ 0.5 % |
| Residual solvent acetone | ≤ 0.1 % |
| Residual solvent toluene | ≤ 890 PPM |
| Total Residual solvent | ≤ 1000 PPM |
| Acid number | 8 - 15 mg KOH/g |
| Heavy metal | ≤ 10 PPM |
| Tin | ≤ 200 PPM |
| Particle size | ≤ 5 µ |
| Sulphated Ash | ≤ 0.1 % |
| TAMC | ≤ 2000 CFU/g |
| TYMC | ≤ 200 CFU/g |
| Bacterial Endotoxins | ≤ 2000 EU/g |
| Self life | 2 Years |
| See also: | PLLA |